Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Panay

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Expert Review of Clinical Pharmacology|June 6, 2023
Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts' perspectiveSerge Rozenberg, Nick Panay, Marco Gambacciani, et al.
Menopause International|September 10, 2011
Stopping hormone replacement therapy: were women ill advised?Grant P Cumming, Heather D Currie, Nick Panay, et al.
Journal of Gynecology Obstetrics and Human Reproduction|June 27, 2021
Real-World Practices and Attitudes Towards Intimate Self- Care: Results From An International Women's SurveyProf Filippo Murina, Alessandra Graziottin, Odile Bagot, et al.
Maturitas|June 10, 2022
Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trialMonica Mittal, Carmel McEniery, Prasanna Raj Supramaniam, et al.
Climacteric : the Journal of the International Menopause Society|September 13, 2024
Menopause and MHT in 2024: addressing the key controversies - an International Menopause Society White PaperNick Panay, Seng Bin Ang, Rebecca Cheshire, et al.
Journal of Women'S Health (2002)|February 17, 2010
Lifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton Women's SurveyCarrie Sadler, Helen Smith, Julia Hammond, et al.
Maturitas|January 16, 2021
Premature ovarian insufficiency: A toolkit for the primary care physicianIrene Lambrinoudaki, Stavroula A Paschou, Mary Ann Lumsden, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 9, 2026
Modern Management of the Menopause: Are We Measuring What Matters?Joscelyn Gan, Michelle Steeper, Tim Hillard, et al.
Human Reproduction Update|January 18, 2023
Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic reviewScott M Nelson, Susan R Davis, Sophia Kalantaridou, et al.
Menopause International|September 28, 2013
A randomised controlled trial comparing the effects of micronized progesterone to medroxyprogesterone acetate on cardiovascular health, lipid metabolism and the coagulation cascade in women with premature ovarian insufficiency: study protocol and review of the literatureMonica Mittal, Michael Savvas, Roopen Arya, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Expert Review of Clinical Pharmacology|June 6, 2023
Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts' perspectiveSerge Rozenberg, Nick Panay, Marco Gambacciani, et al.
Menopause International|September 10, 2011
Stopping hormone replacement therapy: were women ill advised?Grant P Cumming, Heather D Currie, Nick Panay, et al.
Journal of Gynecology Obstetrics and Human Reproduction|June 27, 2021
Real-World Practices and Attitudes Towards Intimate Self- Care: Results From An International Women's SurveyProf Filippo Murina, Alessandra Graziottin, Odile Bagot, et al.
Maturitas|June 10, 2022
Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trialMonica Mittal, Carmel McEniery, Prasanna Raj Supramaniam, et al.
Climacteric : the Journal of the International Menopause Society|September 13, 2024
Menopause and MHT in 2024: addressing the key controversies - an International Menopause Society White PaperNick Panay, Seng Bin Ang, Rebecca Cheshire, et al.
Journal of Women'S Health (2002)|February 17, 2010
Lifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton Women's SurveyCarrie Sadler, Helen Smith, Julia Hammond, et al.
Maturitas|January 16, 2021
Premature ovarian insufficiency: A toolkit for the primary care physicianIrene Lambrinoudaki, Stavroula A Paschou, Mary Ann Lumsden, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 9, 2026
Modern Management of the Menopause: Are We Measuring What Matters?Joscelyn Gan, Michelle Steeper, Tim Hillard, et al.
Human Reproduction Update|January 18, 2023
Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic reviewScott M Nelson, Susan R Davis, Sophia Kalantaridou, et al.
Menopause International|September 28, 2013
A randomised controlled trial comparing the effects of micronized progesterone to medroxyprogesterone acetate on cardiovascular health, lipid metabolism and the coagulation cascade in women with premature ovarian insufficiency: study protocol and review of the literatureMonica Mittal, Michael Savvas, Roopen Arya, et al.
Pageof 8